Product Description
This digital document is an article from Skin & Allergy News, published by International Medical News Group on January 1, 2003. The length of the article is 433 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Interleukin-12 trials generate regression in CTCL. (Phase I and Phase II Trials).(cutaneous T-cell lymphomas)Author: Diana MahoneyPublication: Skin & Allergy News (Magazine/Journal)Date: January 1, 2003Publisher: International Medical News GroupVolume: 34 Issue: 1 Page: 36(2)Distributed by Thomson Gale